Immunoliposomal drug-delivery system targeting lectin-like oxidized low-density lipoprotein receptor–1 for carotid plaque lesions in rats

Laboratory investigation

Atsushi Saito Tohoku University Hospital, Emergency Center, and

Search for other papers by Atsushi Saito in
Current site
Google Scholar
PubMed Close
 M.D., Ph.D.
,
Hiroaki Shimizu Department of Neuroendovascular Therapy, Tohoku University Graduate School of Medicine, Sendai;

Search for other papers by Hiroaki Shimizu in
Current site
Google Scholar
PubMed Close
 M.D., Ph.D.
,
Yusuke Doi Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, University of Tokushima, Tokushima;

Search for other papers by Yusuke Doi in
Current site
Google Scholar
PubMed Close
 Ph.D.
,
Tatsuhiro Ishida Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, University of Tokushima, Tokushima;

Search for other papers by Tatsuhiro Ishida in
Current site
Google Scholar
PubMed Close
 Ph.D.
,
Miki Fujimura Department of Neurosurgery, Konan Hospital, Sendai; and

Search for other papers by Miki Fujimura in
Current site
Google Scholar
PubMed Close
 M.D., Ph.D.
,
Takashi Inoue Department of Neurosurgery, Konan Hospital, Sendai; and

Search for other papers by Takashi Inoue in
Current site
Google Scholar
PubMed Close
 M.D., Ph.D.
,
Hiroshi Kiwada Department of Pharmacokinetics and Biopharmaceutics, Subdivision of Biopharmaceutical Sciences, Institute of Health Biosciences, University of Tokushima, Tokushima;

Search for other papers by Hiroshi Kiwada in
Current site
Google Scholar
PubMed Close
 Ph.D.
, and
Teiji Tominaga Department of Neurosurgery, Tohoku University Graduate School of Medicine, Sendai, Japan

Search for other papers by Teiji Tominaga in
Current site
Google Scholar
PubMed Close
 M.D., Ph.D.
Page Range:
720–727
Volume/Issue:
Volume 115: Issue 4
DOI link:
https://doi.org/10.3171/2011.5.JNS10227
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $525.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $624.00
Click here for subscription options

  • Purchase Now

    USD  $45.00

  • JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

    USD  $525.00

  • JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

    USD  $624.00
USD  $45.00
USD  $525.00
USD  $624.00
Print or Print + Online Sign in

Object

Targeted drug delivery with immunoliposomes has been applied to various in vivo animal models and is newly focused as a novel therapeutic target. Lectin-like oxidized low-density lipoprotein receptor–1 (LOX1) is a potent regulator of systemic atherosclerosis, and the authors focused on its effect on carotid plaques. The authors developed a LOX1-targeted liposomal rho-kinase inhibitor and examined the therapeutic effect on carotid intimal hypertrophy in rats.

Methods

LOX1-targeted rho-kinase inhibitor fasudil-containing liposomes, composed of hydrogenated soy phosphatidylcholine/cholesterol/PEG2000-DSPE, were prepared by conjugating anti-LOX1 antibodies on the surface and by remote loading of fasudil. Carotid intimal hypertrophy was induced by balloon injury, and the drugs were intravenously administered on Day 3 postinjury. The rats were divided into 4 groups: nontreatment, treatment with intravenous fasudil (2 mg), treatment with liposomal fasudil (2 mg), and treatment with LOX1-targeted liposomal fasudil (2 mg). The authors compared intimal hypertrophy, atherosclerotic factor, and matrix metalloproteinase-9 expression among groups.

Results

DiI–labeled LOX1-targeted liposomes were prominently observed in the lesions on Day 7 after the surgery. The intimal thickness was significantly reduced in the LOX1-targeted liposomal fasudil–treated group (mean 81.6 ± 13.9 μm) compared with the other groups (no treatment 105.4 ± 16.8 μm; fasudil treatment 102.4 ± 20.0 μm; and liposomal fasudil treatment 102.8 ± 22.2 μm; p = 0.046). Matrix metalloproteinase-9 expression was also significantly reduced in the LOX1-targeted liposomal fasudil group.

Conclusions

Liposomes conjugated with anti-LOX1 antibody effectively reached carotid artery lesions, and liposomal rho-kinase significantly inhibited intimal hypertrophy. The new liposomal drug delivery system targeting LOX1 may become a therapeutic strategy for atherosclerotic diseases.

Abbreviations used in this paper:

HSPC = high-purity hydrogenated soy phosphatidylcholine cholesterol; LOX1 = lectin-like oxidized low-density lipoprotein receptor–1; MMP = matrix metalloproteinase; oxLDL = oxidized low-density lipoprotein.
  • Collapse
  • Expand

Contributor Notes

Address correspondence to: Atsushi Saito, M.D., Ph.D., Department of Neurosurgery, Tohoku University, 1-1 Seiryomachi, Aoba, Sendai, Miyagi, 980-8574 Japan. email: satsushi2002@yahoo.co.jp.

Please include this information when citing this paper: published online June 17, 2011; DOI: 10.3171/2011.5.JNS10227.

  • 1

    Allen TM, , Hansen C, , Martin F, , Redemann C, & Yau-Young A: Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1066:29–36, 1991

    • Search Google Scholar
    • Export Citation
  • 2

    Chen XP, , Zhang TT, & Du GH: Lectin-like oxidized low-density lipoprotein receptor-1, a new promising target for the therapy of atherosclerosis?. Cardiovasc Drug Rev 25:146–161, 2007

    • Search Google Scholar
    • Export Citation
  • 3

    Cho A, & Reidy MA: Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury. Circ Res 91:845–851, 2002

    • Search Google Scholar
    • Export Citation
  • 4

    Gabizon A, , Catane R, , Uziely B, , Kaufman B, , Safra T, & Cohen R, et al.: Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54:987–992, 1994

    • Search Google Scholar
    • Export Citation
  • 5

    Hinagata J, , Kakutani M, , Fujii T, , Naruko T, , Inoue N, & Fujita Y, et al.: Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model. Cardiovasc Res 69:263–271, 2006

    • Search Google Scholar
    • Export Citation
  • 6

    Ishida T, , Takanashi Y, , Doi H, , Yamamoto I, & Kiwada H: Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes. Int J Pharm 232:59–67, 2002

    • Search Google Scholar
    • Export Citation
  • 7

    Ishino S, , Mukai T, , Kuge Y, , Kume N, , Ogawa M, & Takai N, et al.: Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque. J Nucl Med 49:1677–1685, 2008

    • Search Google Scholar
    • Export Citation
  • 8

    Jain RK: Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6:559–593, 1987

  • 9

    Kataoka H, , Kume N, , Miyamoto S, , Minami M, , Moriwaki H, & Murase T, et al.: Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99:3110–3117, 1999

    • Search Google Scholar
    • Export Citation
  • 10

    Klibanov AL, , Maruyama K, , Torchilin VP, & Huang L: Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett 268:235–237, 1990

    • Search Google Scholar
    • Export Citation
  • 11

    Lasic DD, , Martin FJ, , Gabizon A, , Huang SK, & Papahadjopoulos D: Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta 1070:187–192, 1991

    • Search Google Scholar
    • Export Citation
  • 12

    Lopes de Menezes DE, , Kirchmeier MJ, , Gagne J, , Pilarski LM, & Allen TM: Cellular trafficking and cytotoxicity of anti-CD19-targeted liposomal doxorubicin in B lymphoma cells. J Liposome Res 9:199–228, 1999

    • Search Google Scholar
    • Export Citation
  • 13

    Mamot C, , Drummond DC, , Noble CO, , Kallab V, , Guo Z, & Hong K, et al.: Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo. Cancer Res 65:11631–11638, 2005

    • Search Google Scholar
    • Export Citation
  • 14

    Papahadjopoulos D, , Allen TM, , Gabizon A, , Mayhew E, , Matthay K, & Huang SK, et al.: Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci U S A 88:11460–11464, 1991

    • Search Google Scholar
    • Export Citation
  • 15

    Sawada M, , Yanamoto H, , Nagata I, , Hashimoto N, , Nakahara I, & Akiyama Y, et al.: Prevention of neointimal formation by a serine protease inhibitor, FUT-175, after carotid balloon injury in rats. Stroke 30:644–650, 1999

    • Search Google Scholar
    • Export Citation
  • 16

    Scott RC, , Rosano JM, , Ivanov Z, , Wang B, , Chong PLG, & Issekutz AC, et al.: Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function. FASEB J 23:3361–3367, 2009

    • Search Google Scholar
    • Export Citation
  • 17

    Senior J, , Delgado C, , Fisher D, , Tilcock C, & Gregoriadis G: Influence of surface hydrophilicity of liposomes on their interaction with plasma protein and clearance from the circulation: studies with poly(ethylene glycol)-coated vesicles. Biochim Biophys Acta 1062:77–82, 1991

    • Search Google Scholar
    • Export Citation
  • 18

    Shibata R, , Kai H, , Seki Y, , Kato S, , Morimatsu M, & Kaibuchi K, et al.: Role of Rho-associated kinase in neointima formation after vascular injury. Circulation 103:284–289, 2001

    • Search Google Scholar
    • Export Citation
  • 19

    Shimokawa H, , Morishige K, , Miyata K, , Kandabashi T, , Eto Y, & Ikegaki I, et al.: Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovasc Res 51:169–177, 2001

    • Search Google Scholar
    • Export Citation
  • 20

    Takanashi Y, , Ishida T, , Kirchmeier MJ, , Shuaib A, & Allen TM: Neuroprotection by intrathecal application of liposome-entrapped fasudil in a rat model of ischemia. Neurol Med Chir (Tokyo) 41:107–114, 2001

    • Search Google Scholar
    • Export Citation
  • 21

    Takanashi Y, , Ishida T, , Meguro T, , Kirchmeier MJ, , Allen TM, & Zhang JH: Intrathecal application with liposome-entrapped Fasudil for cerebral vasospasm following subarachnoid hemorrhage in rats. J Clin Neurosci 8:557–561, 2001

    • Search Google Scholar
    • Export Citation
  • 22

    Takanashi Y, , Ishida T, , Meguro T, , Kiwada , Zhang JH, & Yamamoto I: Efficacy of intrathecal liposomal Fasudil for experimental cerebral vasospasm following subarachnoid hemorrhage. Neurosurgery 48:894–901, 2001

    • Search Google Scholar
    • Export Citation
  • 23

    Torchilin VP, , Omelyanenko VG, , Papisov MI, , Bogdanov AA Jr, , Trubetskoy VS, & Herron JN, et al.: Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochim Biophys Acta 1195:11–20, 1994

    • Search Google Scholar
    • Export Citation
  • 24

    Witztum JL, & Steinberg D: Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785–1792, 1991

Metrics

All Time Past Year Past 30 Days
Abstract Views 548 85 5
Full Text Views 120 4 0
PDF Downloads 91 5 0
EPUB Downloads 0 0 0